Money laundering case: Sterling Biotech's director arrested sent to ED custody

Published On 2018-01-27 04:30 GMT   |   Update On 2018-01-27 04:30 GMT

New Delhi: A Director of Gujarat-based pharma firm was Friday sent to the one-day custody of Enforcement Directorate, which arrested him last night in a money laundering case related to an alleged Rs 5,000 crore bank fraud case.


Metropolitan Magistrate Sumeet Anand sent Rajbhushan Omprakash Dixit to custody after special public prosecutor Nitesh Rana, appearing for the ED, said his custodial interrogation was required.


The ED had sought 14 days custody of the accused.


The magistrate, who was on special duty on Friday, directed the agency to produced the accused before the court concerned on Saturday.


This is the third arrest in the case. The agency had earlier this month arrested a former Director of Andhra Bank, Anup Prakash Garg, and a Delhi-based businessman Gagan Dhawan in November last year.


Read also: ED arrests former Andhra Bank director in Sterling Biotech loan fraud case

While Garg is currently in judicial custody, Dhawan was granted bail on January 4. All three were arrested under the Prevention of Money Laundering Act (PMLA).


They were named as accused in the cases by the ED and the CBI.


The ED registered a money laundering case in this instance after taking cognizance of an earlier CBI FIR.


The CBI had booked Sterling Biotech, its directors Chetan Jayantilal Sandesara, Chetan Sandesara, Rajbhushan Omprakash Dixit, Nitin Jayantilal Sandesara and Vilas Joshi, chartered accountant Hemant Hathi, Garg and some unidentified persons in connection with the alleged bank fraud case.


Read also: Non-bailable warrants issued against Sterling Biotech directors in Rs 5,000 crore fraud case

It had alleged that the company had taken loans of over Rs 5,000 crore from a consortium led by Andhra Bank which had turned into non-performing assets.


The FIR had also alleged that the total pending dues of the group companies were Rs 5,383 crore as on December 31, 2016.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News